Parallel Advisors, LLC Biotechnology

Parallel Advisors, LLC

$4.34 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TERN Terns Pharmaceuticals, Inc.	$139M	$1,000 0.0% of portfolio	337	Q2 2024 Added 59.72%
VXRT Vaxart, Inc.	$64.5M	$1,000 0.0% of portfolio	3,000	Q2 2023 Reduced 2.45%
WVE Wave Life Sciences Ltd.	$918M	$1,000 0.0% of portfolio	95	Q1 2023 New
AADI Aadi Bioscience, Inc.	$53.8M	$0 0.0% of portfolio	8	Q2 2024 Reduced 100.0%
ADAP Adaptimmune Therapeutics PLC	$88.2M	$0 0.0% of portfolio	250	Q4 2024 Reduced 96.52%
ALLK Allakos Inc.	$23.7M	$0 0.0% of portfolio	770	Q2 2024 Reduced 37.35%
ALLO Allogene Therapeutics, Inc.	$280M	$0 0.0% of portfolio	221	Q2 2024 New
ALT Altimmune, Inc.	$326M	$0 0.0% of portfolio	40	Q3 2022 Reduced 90.91%
AMRN Amarin Corp Plcuk	$218M	$0 0.0% of portfolio	200	Q4 2022 Reduced 87.58%
ACLX Arcellx, Inc.	$2.84B	$0 0.0% of portfolio	6	Q4 2024 Reduced 40.0%
ARQT Arcutis Biotherapeutics, Inc.	$824M	$0 0.0% of portfolio	28	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	17	Q4 2024 New
AUPH Aurinia Pharmaceuticals Inc.	$1.13B	$0 0.0% of portfolio	43	Q4 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.6B	$0 0.0% of portfolio	93	Q4 2024 Reduced 25.0%
CAPR Capricor Therapeutics, Inc.	$374M	$0 0.0% of portfolio	13	Q4 2024 New
SAVA Cassava Sciences Inc	$96.2M	$0 0.0% of portfolio	244	Q2 2024 Reduced 3.94%
CPRX Catalyst Pharmaceuticals, Inc.	$2.35B	$0 0.0% of portfolio	27	Q4 2024 Added 107.69%
KDNY Chinook Therapeutics, Inc.	$0	$0 0.0% of portfolio	5	Q3 2023 Reduced 80.77%
CDXS Codexis, Inc.	$199M	$0 0.0% of portfolio	200	Q3 2023 Reduced 50.0%
DAWN Day One Biopharmaceuticals, Inc.	$666M	$0 0.0% of portfolio	4	Q4 2024 New
DYN Dyne Therapeutics, Inc.	$705M	$0 0.0% of portfolio	27	Q4 2024 Reduced 3.57%
EDIT Editas Medicine, Inc.	$132M	$0 0.0% of portfolio	60	Q3 2024 Reduced 74.47%
TRDA Entrada Therapeutics, Inc.	$355M	$0 0.0% of portfolio	16	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$293M	$0 0.0% of portfolio	200	Q3 2023 Reduced 75.7%
IMUX Immunic, Inc.	$36.4M	$0 0.0% of portfolio	2	Q2 2019 New
IMNM Immunome Inc.	$114M	$0 0.0% of portfolio	93	Q4 2024 Added 232.14%
JANX Janux Therapeutics, Inc.	$1.37B	$0 0.0% of portfolio	2	Q4 2024 Reduced 90.91%
KALV Kal Vista Pharmaceuticals, Inc.	$280M	$0 0.0% of portfolio	103	Q4 2024 Added 51.47%
KYMR Kymera Therapeutics, Inc.	$1.72B	$0 0.0% of portfolio	13	Q4 2024 Reduced 38.1%
NUVL Nuvalent, Inc.	$3.22B	$0 0.0% of portfolio	1	Q4 2024 Reduced 88.89%
OCUL Ocular Therapeutix, Inc	$550M	$0 0.0% of portfolio	1	Q3 2024 New
PRTA Prothena Corp Public LTD CO	$672M	$0 0.0% of portfolio	70	Q4 2024 New
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	295	Q2 2024 Reduced 5.14%
RGNX Regenxbio Inc.	$284M	$0 0.0% of portfolio	50	Q2 2023 Reduced 7.41%
SANA Sana Biotechnology, Inc.	$497M	$0 0.0% of portfolio	180	Q4 2024 New
SLDB Solid Biosciences Inc.	$42.1M	$0 0.0% of portfolio	7	Q2 2024 Added 16.67%
STRO Sutro Biopharma, Inc.	$82.9M	$0 0.0% of portfolio	465	Q3 2023 Added 0.19%
CBIO Catalyst Biosciences, Inc.	$0	$0 0.0% of portfolio	15	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$77.4M	$0 0.0% of portfolio	280	Q2 2024 New
TPST Tempest Therapeutics, Inc.	$8.44M	$0 0.0% of portfolio	235	Q3 2024 Reduced 0.42%
VNDA Vanda Pharmaceuticals Inc.	$269M	$0 0.0% of portfolio	87	Q2 2023 Added 188.5%
VERA Vera Therapeutics, Inc.	$809M	$0 0.0% of portfolio	2	Q4 2024 Reduced 86.67%
VERV Verve Therapeutics, Inc.	$379M	$0 0.0% of portfolio	23	Q3 2024 New
VIRX Viracta Therapeutics, Inc.	$751K	$0 0.0% of portfolio	8	Q1 2021 New
VRDN Viridian Therapeutics, Inc.\De	$619M	$0 0.0% of portfolio	10	Q4 2024 Reduced 64.29%
VYGR Voyager Therapeutics, Inc.	$158M	$0 0.0% of portfolio	163	Q4 2024 New
ZLAB Zai Lab LTD	$3.39B	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.